Ascend specializes in advanced therapy manufacturing, focusing on identifying and balancing quality and yield appropriate for clients' processes.

Ascend Advanced Therapies

Ascend

Ascend Advanced Therapies | 10,314 followers on LinkedIn. Ascend is a gene therapy development partner with a flexible platform featuring industry-leading analytics.  | Ascend is gene to GMP partner with deep expertise in gene therapy development and commercialization. 

We offer unparalleled collaboration while working to develop your products from the bench through the clinic and beyond. Scientific innovation driven by quality and responsibility are at the core of our business.

Hongjie Hu

Digital Technology Leader at NBCUniversal for News Group Digital

Trinh Nguyen

Karim Pirani

CEO of Ascend Advanced Therapies

Mike Stella

We continue growing and evolving. Today, we are thrilled to align with ABL to deepen our commitment to being an exceptional advanced #therapies #partner . The addition of the ABL Rockville team and facility aligns more than three decades of development and manufacturing experience with additional virus modalities and GMP capacity for adeno-associated virus (AAV) production. The merger also expands fill/finish capacity in the US making the combined group one of the few suppliers with a comprehensive R&D to commercial offering in the market. https://lnkd.in/eAYwrgds

According to the Q3 2024 American Society of Gene & Cell Therapy report, "2,042 gene therapies (including genetically modified #cell therapies such as CAR-T cell therapies) are in development, accounting for 49% of gene, cell, and RNA therapies." It is hard to believe the amount of progress being made, and there is only more #genetherapy #innovation on the horizon! Read the full report here: https://lnkd.in/gvJwu4Yd

How do you develop a fully scalable #genetherapy process with high product yield and vector #quality ? Our team explored this topic in ESGCT poster 0031 in Rome last month: https://lnkd.in/eP7H7f3Y

Look at this whole team dressed up as builders of the #future of #genetherapy ! It's spooky 🎃 what a bootifiul time we had in Rome last week at the European Society of Gene and Cell Therapy Congress connecting & sharing our passion for progress. Thank you for visiting and feel free to reach out any time at business@ascend-adv.com . Are you in a fright that you didn't get a chance to see our team or posters onsite? Have we got a treat for you: https://lnkd.in/dD3-_MJ8

And just like that, the time in #Rome for the European Society of Gene and Cell Therapy has flown by! We had an enjoyable AND educational time throughout the week, including the chance to share 12 posters on our #genetherapy #innovation . Were you stuck at home, or just didn't have a chance to see everything onsite? No worries. Find our posters here and feel free to reach out with questions any time at business@ascend-adv.com . https://lnkd.in/dD3-_MJ8

Are you in Rome and you missed Philipp Beck talking about enhanced #genetherapy 🧬 #formulation at the European Society of Gene and Cell Therapy ? No worries! 🎁 Here's a video of him offering a rundown of poster P0157 on a 2-day turnaround:

The European Society of Gene and Cell Therapy Congress starts tomorrow, and we cannot wait to see everyone onsite! Find us in booth A1 or visit one of our MANY #genetherapy poster sessions. What will be covering, you might ask? Here's a quick overview of what our team is talking about during the evening sessions:

The clock is ticking ⏰ ... and our team is getting ready to make their way 🛫 to Rome to share #genetherapy information and network at the European Society of Gene and Cell Therapy Congress next week! We will be in booth A1 and have multiple posters in both sessions, but you can also find us in the app to schedule time, or say hello anytime at business@ascend-adv.com .

“A good CDMO [should] have structured #communication , because communication is key … when you're talking to your business partner. We always build that in a more collaborative environment,” says Ahmed Youssef . “[A CDMO needs] to protect the IP rights of their clients, their partners, as well as good documentation practices, in addition to a solid IT department. All of that gives the assurance to the security of the data and the security of the transfer information between the CDMO and their partner.” Want to hear more on #genetherapy tech transfer? Check out the full chat with MJH Life Sciences® PharmTech team by clicking below:

October seems to be flying by, but we have one more stop to make before the month is over! We will be in Rome next week for the European Society of Gene and Cell Therapy (ESGCT) Congress and we'd love to chat about #genetherapy #innovation over at booth A1 or in the #poster hall. More details on our exciting poster topics to follow... https://lnkd.in/efye-f8c

ASCE

COM:ASCEND-ADV

Ascend

name

homepage url

country

linkedin url

sector

industry

Description

investor of

competitor of

Metrics